FGR
feline Gardner-Rasheed sarcoma viral oncogene homolog
FGR; feline Gardner-Rasheed sarcoma viral oncogene homolog; SRC2; c-fgr; c-src2; p55-Fgr; p58-Fgr; p55c-fgr; p58c-fgr; tyrosine-protein kinase Fgr; p55-c-fgr protein; c-fgr protooncogene; proto-oncogene c-Fgr; c-src-2 proto-oncogene; proto-oncogene tyrosine-protein kinase FGR; v-fgr feline Gardner-Rasheed sarcoma viral oncogene homolog; Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog;
PPK
ppk polyphosphate kinase [ Propionibacterium freudenreichii subsp. shermanii CIRM-BIA1 ]
ppk; polyphosphate kinase; PFREUD_19930;
PRKAR1A
protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)
PRKAR1A; protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1); PRKAR1, TSE1; cAMP-dependent protein kinase type I-alpha regulatory subunit; tissue-specific extinguisher 1; protein kinase A type 1a regulatory subunit;
USH1C
Usher syndrome 1C (autosomal recessive, severe)
USH1C; Usher syndrome 1C (autosomal recessive, severe); deafness, autosomal recessive 18 , DFNB18; harmonin; AIE 75; NY CO 37; NY CO 38; PDZ 73; PDZ73; antigen NY-CO-38/NY-CO-37; usher syndrome type-1C protein; renal carcinoma antigen NY-REN-3; autoimmune;
DVL3
dishevelled segment polarity protein 3
DVL3; dishevelled segment polarity protein 3; segment polarity protein dishevelled homolog DVL-3; DSH homolog 3; dishevelled-3; dishevelled, dsh homolog 3; dishevelled 3 (homologous to Drosophila dsh);
DVL1
dishevelled, dsh homolog 1 (Drosophila)
DVL1; dishevelled, dsh homolog 1 (Drosophila); dishevelled 1 (homologous to Drosophila dsh); segment polarity protein dishevelled homolog DVL-1; Dishevelled 1; dishevelled 1 like; Dishevelled; Dishevelled dsh homolog 1; Dishevelled-1; Dishevelled1; DSH homolog 1; Dvl 1; Dvl; DVL1_HUMAN; DVL1L1; MGC54245; Segment polarity protein dishevelled homolog DVL 1; segment polarity protein dishevelled homolog DVL 1 like; Segment polarity protein dishevelled homolog DVL1;
Dact1
dishevelled-binding antagonist of beta-catenin 1
DACT1; dishevelled-binding antagonist of beta-catenin 1; DPR1; FRODO; HDPR1; DAPPER; THYEX3; DAPPER1; dapper homolog 1; dapper antagonist of catenin 1; heptacellular carcinoma novel gene 3; dapper, antagonist of beta-catenin, homolog 1; hepatocellular carcinoma novel gene 3 protein;
DAAM1
dishevelled associated activator of morphogenesis 1
DAAM1; dishevelled associated activator of morphogenesis 1; disheveled-associated activator of morphogenesis 1; KIAA0666; FLJ41657;
DAAM2
dishevelled associated activator of morphogenesis 2
DAAM2; dishevelled associated activator of morphogenesis 2; disheveled-associated activator of morphogenesis 2; KIAA0381; dishevelled-associated activator of morphogenesis 2; dJ90A20A.1; RP1-278E11.1; MGC90515;
DVL2
dishevelled, dsh homolog 2
DVL2; dishevelled, dsh homolog 2 (Drosophila); dishevelled 2 (homologous to Drosophila dsh); segment polarity protein dishevelled homolog DVL-2; DSH homolog 2; dishevelled-2;
USH2A
Usher syndrome 2A (autosomal recessive, mild)
USH2A; Usher syndrome 2A (autosomal recessive, mild); USH2; usherin; RP39; dJ1111A8.1; US2; Usher syndrome type IIa protein; Usher syndrome type-2A protein; OTTHUMP00000035145; OTTHUMP00000063383;
FSIP1
fibrous sheath interacting protein 1
FSIP1; fibrous sheath interacting protein 1; fibrous sheath-interacting protein 1; FLJ35989; HSD10;
USH1G
Usher syndrome 1G (autosomal recessive)
USH1G; Usher syndrome 1G (autosomal recessive); Usher syndrome type-1G protein; ANKS4A; FLJ33924; Sans; scaffold protein containing ankyrin repeats and SAM domain;
SHE
Src homology 2 domain containing E
SHE;Src homology 2 domain containing E;27004;ENSG00000169291;RP11-350G8.8;1q21.3;DKFZp451D1511, DKFZp686E14106;SH2 domain-containing adapter protein E;SH2 domain-containing adapter protein E;
FSCB
FSCB fibrous sheath CABYR binding protein [ Homo sapiens ]
fibrous sheath CA; 20494; Ensembl:ENSG00000189139; DKFZp434F1017, DKFZp686A1639, DKFZp686J0539; fibrous sheath CABYR-binding protein; C14orf155;
A New Effective and Accurate New Technology to Edit genome was Found by MIT and Published on Science Online
On the online edition of Science, you will find a report said that researchers from MIT, the Broad Institute and Rockefeller University have developed a new technique for precisely altering the genomes of living cells by adding or deleting genes. This will benefit any research that correlates with g...
Cleveland Clinic Published Its Selection of Top Three “Groundbreaking” Pharmaceutics
As usual, Cleveland Clinic will pick out some groundbreaking pharmaceutics that may make big difference for healthcare industry in their late development stages. This year who will be picked by Cleveland? According to internal news, Gilead's sofosbuvir, Novartis heart drugs serelaxin as well as Phar...
